...
首页> 外文期刊>Journal of Medicinal Chemistry >Synthesis and Enantiomeric Separation of a Novel Spiroketal Derivative: A Potent Human Telomerase Inhibitor with High in Vitro Anticancer Activity
【24h】

Synthesis and Enantiomeric Separation of a Novel Spiroketal Derivative: A Potent Human Telomerase Inhibitor with High in Vitro Anticancer Activity

机译:新型螺环衍生物的合成和对映体分离:具有高体外抗癌活性的有效人端粒酶抑制剂

获取原文
获取原文并翻译 | 示例
           

摘要

The synthesis, the enantiomeric separation, and the characterization of new simple spiroketal derivatives have been performed. The synthesized compounds have shown a very high anticancer activity. Cell proliferation assay showed that they induce a remarkable inhibition of cell proliferation in all cell lines treated, depending on culture time and concentration. The compounds have also shown a potent nanomolar human telomerase inhibition activity and apoptosis induction. CD melting experiments demonstrate that spiroketal does not affect the G-quadruplex (G4) thermal stability. Docking studies showed that telomerase inhibition could be determined by a spiroketal interaction with the telomerase enzyme.
机译:合成,对映体分离和新的简单螺环衍生物的表征已进行。合成的化合物显示出非常高的抗癌活性。细胞增殖试验表明,根据培养时间和浓度,它们可在所有处理的细胞系中诱导显着抑制细胞增殖。所述化合物还显示出有效的纳摩尔人端粒酶抑制活性和细胞凋亡诱导。 CD融化实验表明,螺环酮不会影响G-四链体(G4)的热稳定性。对接研究表明,端粒酶抑制作用可通过与端粒酶的螺旋相互作用来确定。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号